JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263092

Human APOL6 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

APOL6 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2 and 5 bp deletion in exon2.

View Alternative Names

2310076O14Rik, APOL6_HUMAN, ApoL-VI, Apolipoprotein L, 6, Apolipoprotein L-VI, Apolipoprotein L6, DKFZp667M075, FLJ38562, FLJ90164, MGC57495

2 Images
Sanger Sequencing - Human APOL6 knockout A549 cell lysate (AB263092)
  • Sanger seq

Unknown

Sanger Sequencing - Human APOL6 knockout A549 cell lysate (AB263092)

Allele-1 : 5 bp deletion in exon2

Sanger Sequencing - Human APOL6 knockout A549 cell lysate (AB263092)
  • Sanger seq

Unknown

Sanger Sequencing - Human APOL6 knockout A549 cell lysate (AB263092)

Allele-2 : 1 bp deletion in exon2

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2 and 5 bp deletion in exon2.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263092-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human APOL6 knockout A549 cell lysate", "number":"AB263092-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB263092-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
APOL6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

APOL6 also known as apolipoprotein L6 is a protein with an approximate molecular mass of 41 kDa. Expressed primarily in the liver kidney and heart APOL6 plays a critical role in modulating lipid metabolism. As a member of the apolipoprotein L family APOL6 is involved in lipid binding and transport which are essential processes for maintaining lipid homeostasis in the cell.
Biological function summary

APOL6 influences important cellular processes such as apoptosis and lipid metabolic processes. Although not part of a large protein complex APOL6 contributes significantly to the regulation of phospholipid transport and stability within cellular membranes. Through these functions APOL6 supports cellular homeostasis and impacts the regulation of cell death pathways.

Pathways

Lipid metabolism and cell signaling heavily involve APOL6. It interacts with other apolipoproteins and factors like cholesterol transport proteins. Within the lipid metabolic pathway APOL6 facilitates proper lipid transport working closely with apolipoprotein E (ApoE) which is another key player in these processes. Disruption of this interaction can lead to imbalances in lipid homeostasis affecting overall health.

APOL6 has been linked to conditions like cardiovascular disease and specific forms of cancer. Its involvement in lipid metabolism and apoptosis suggests that alterations in APOL6 function or expression may lead to these health issues. APOL6 connects to proteins such as ApoE in cardiovascular diseases due to their shared roles in lipid transport and metabolism which directly affects plaque formation and cell health in blood vessels. Understanding these relationships helps in targeting therapeutic interventions.

Quality control

STR analysis

D7S820, D5S818, TH01, D16S539, TPOX, CSF1PO, D13S317

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com